Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

Table 2 Frequency and proportion of the 211 men in the P3P intervention and control group who made a concordant treatment choice by 6-months given their concerns about influential side effects (bladder, sex, and bowel) at enrollment

Influential Side Effects	Overall		Active surveillance		External Beam Radiotherapy		Brachytherapy		Radical Prostatectomy
	Intervention N = 107	Control N = 104	Intervention N = 15	Control N = 24	Intervention N = 15	Control N = 13	Intervention N = 16	Control N = 7	Intervention N = 61	Control N = 60
	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)
All ^a	8 (7.5)	14 (13)	8 (53)	14 (58)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Bowel ^b	31 (29)	32 (31)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	31 (51)	32 (53)
Sex ^c	7 (6.5)	8 (7.7)	0 (0)	0 (0)	5 (33)	7 (54)	2 (13)	1 (14)	0 (0)	0 (0)
Bowel and Sex ^d	0 (0)	1 (1.0)	0 (0)	1 (4.2)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Bladder ^e	1 (0.9)	2 (1.9)	1 (6.7)	2 (8.3)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
None ^f	60 (56)	47 (45)	6 (40)	7 (29)	10 (67)	6 (46)	14 (88)	6 (86)	30 (49)	28 (47)
p-value ^g	0.29		0.05		0.65		0.97		0.71

a. Concerned about bladder, sexual, and bowel dysfunction concordant with active surveillance.
b. Concerned about bowel dysfunction concordant with radical prostatectomy.
c. Concerned about sexual dysfunction concordant with external beam radiotherapy and brachytherapy.
d. Concerned about bowel and sex dysfunction concordant with active surveillance.
e. Concerned about bladder dysfunction concordant with active surveillance.
f. Not concerned about any influential side effects concordant with all treatment choices.
g. p-value to test difference in concordance between intervention and control group.

ISSN: 1477-7525